Izidore Lossos

Medicine & Life Sciences

1. Lymphoma, Large B-Cell, Diffuse 100%
2. Lymphoma 93%
3. Germinal Center 58%
4. B-Lymphocytes 39%
5. Non-Hodgkin's Lymphoma 35%
6. Follicular Lymphoma 32%
7. B-Cell Lymphoma 26%
8. Rituximab 26%
9. Survival 26%
10. Mantle-Cell Lymphoma 22%
11. human GCSAM protein 20%
12. Neoplasms 17%
13. Marginal Zone B-Cell Lymphoma 17%
14. Genes 16%
15. Progression-Free Survival 15%
16. Bleomycin 14%
17. Hodgkin Disease 13%
18. Lung Injury 13%
19. Drug Therapy 12%
20. Chlamydophila psittaci 12%
21. Therapeutics 11%
22. Mutation 10%
23. Central Nervous System 10%
24. T-Cell Lymphoma 10%
25. Eye 10%
26. Gene Expression 9%
27. Lenalidomide 9%
28. Interleukin-4 8%
29. Immunoglobulin Genes 8%
30. Proteins 8%
31. Gene Expression Profiling 8%
32. Lymphocytes 8%
33. T-Lymphocytes 7%
34. Burkitt Lymphoma 7%
35. Recurrence 7%
36. interleukin-21 7%
37. Lymphoid Tissue 6%
38. Peripheral T-Cell Lymphoma 6%
39. Primary Effusion Lymphoma 6%
40. Bendamustine Hydrochloride 6%
41. L-Lactate Dehydrogenase 6%
42. Positron-Emission Tomography 6%
43. Precursor Cell Lymphoblastic Leukemia-Lymphoma 5%
44. darinaparsin 5%
45. Human Herpesvirus 4 5%
46. Bortezomib 5%
47. Biopsy 5%
48. Radiotherapy 5%
49. Apoptosis 5%